MOVING THE NEEDLE

Serum Institute of India’s Covishield production

90 million/month Current production

100 million/month By August

500 million doses Covishield availability between August and December 2021

200 million/month Scale-up plan in 2022

1.2 billion Annual capacity at 100 million doses/month

2.4 billion Annual capacity at 200 million doses/month

50 million/month Targeted production of Covovax (Novavax) by September 2021

1.5 billion doses Annual noncovid vaccine production in 2019-20

4 billion-plus doses Covid and non-covid vaccine production by end-2022